17 Oct 2022 --- Bioiberica is set to demonstrate innovations for a healthier life through its complete pharma-nutra ingredient portfolio at CPHI 2022 in Frankfurt, Germany (November 1-3). Its combined offering of biologically-derived active pharmaceutical ingredients (APIs) and branded ingredients enables manufacturers to bolster their offering, paving the way for “the health solutions of tomorrow.” The company is a leading heparin manufacturer and world reference in the research, development and production of biologically-derived APIs. Its nutraceutical-branded ingredients will be offered for the first time at CPHI Worldwide 2022, a world-leading pharmaceutical and nutrition trade show.
